Urinary Tract Infection Tracked by Routine and Automated Urinalysis
By LabMedica International staff writers Posted on 13 Sep 2016 |

Image: The UF-1000i fully automated urine particle analyzer (Photo courtesy of Sysmex Corporation).
Urinary tract infections (UTIs) are frequently encountered and the diagnosis of UTI using urine dipstick, Gram stain, urine culture often lack proven accuracy and precision in the emergency department (ED).
Because of its swiftness and low cost, urine dipstick (UD) is a commonly used test at the ED, but diagnostic accuracy is, however, based on primary care settings and therefore not compatible with the ED. UTI is confirmed by results of urine cultures (UCs), which are labor intensive, time consuming, and not available within the time frame of an ED visit.
Scientists at the University Medical Center Groningen (The Netherlands) analyzed a total of 381 cases presenting with fever and/or clinically suspected UTI. The following specific symptoms for UTI were determined: dysuria, pollakisuria, urinary urgency, hematuria, and back pain/lower abdominal pain. In addition, specific symptoms of UTI were determined: fever, chills, malaise, flank or perineal pain, and delirium.
For Gram staining, 10 μL of uncentrifuged urine was used. The color (gram negative or gram positive); shape (rods or cocci); and number of leukocytes, erythrocytes, and bacteria per high-power field (hpf) were determined semi-quantitatively at 100 × 10 magnification. The automated stick reader cobas u 411 was used with the UD Combur10 test (Roche Diagnostics, Mannheim, Germany). For UC, 1 μL of urine was inoculated on two agars (sheep blood agar and MacConkey3 agar) and incubated at 35°C for 16-20 hours in ambient air. Isolated organisms were measured semi-quantitatively as number of colony-forming units (CFU) per milliliter. For automated urine particle analysis, the team used the Sysmex UF-1000i (Sysmex Corporation, Kobe, Japan) is a fully automated urine particle analyzer based on flow cytometry.
The scientists reported 143 (37.5%) cases were diagnosed with UTI. Sensitivity of urine dipstick nitrite was 32.9% and specificity was 93.7%. Sensitivity of urine dipstick leukocyte esterase (3+) was 80.4% and specificity was 82.8%. Of the 143 cases with a UTI, 91 had a noninvasive UTI, 16 had a urosepsis confirmed by blood culture, 24 had a urosepsis based on clinical presentation, 11 had a pyelonephritis, and one had a prostatitis. Receiver operating characteristic curves of automated bacterial and leukocyte count showed area under the curve of 0.851 and 0.872, respectively. Cutoff values of 133 bacteria/μL and 48 leukocytes/μL resulted in a greater than 90% sensitivity.
The authors concluded that that in an unselected patient group presenting to the ED with suspected UTI, automated urine particle analysis with counts of leukocytes and bacteria results in comparable diagnostic accuracy compared with standard dipstick analysis but can slightly improve diagnostic accuracy, especially to make UTI unlikely, when added to standard clinical and UD analysis. The study was published in the August 2016 issue of the American Journal of Emergency Medicine.
Related Links:
University Medical Center Groningen
Roche Diagnostics
Sysmex Corporation
Because of its swiftness and low cost, urine dipstick (UD) is a commonly used test at the ED, but diagnostic accuracy is, however, based on primary care settings and therefore not compatible with the ED. UTI is confirmed by results of urine cultures (UCs), which are labor intensive, time consuming, and not available within the time frame of an ED visit.
Scientists at the University Medical Center Groningen (The Netherlands) analyzed a total of 381 cases presenting with fever and/or clinically suspected UTI. The following specific symptoms for UTI were determined: dysuria, pollakisuria, urinary urgency, hematuria, and back pain/lower abdominal pain. In addition, specific symptoms of UTI were determined: fever, chills, malaise, flank or perineal pain, and delirium.
For Gram staining, 10 μL of uncentrifuged urine was used. The color (gram negative or gram positive); shape (rods or cocci); and number of leukocytes, erythrocytes, and bacteria per high-power field (hpf) were determined semi-quantitatively at 100 × 10 magnification. The automated stick reader cobas u 411 was used with the UD Combur10 test (Roche Diagnostics, Mannheim, Germany). For UC, 1 μL of urine was inoculated on two agars (sheep blood agar and MacConkey3 agar) and incubated at 35°C for 16-20 hours in ambient air. Isolated organisms were measured semi-quantitatively as number of colony-forming units (CFU) per milliliter. For automated urine particle analysis, the team used the Sysmex UF-1000i (Sysmex Corporation, Kobe, Japan) is a fully automated urine particle analyzer based on flow cytometry.
The scientists reported 143 (37.5%) cases were diagnosed with UTI. Sensitivity of urine dipstick nitrite was 32.9% and specificity was 93.7%. Sensitivity of urine dipstick leukocyte esterase (3+) was 80.4% and specificity was 82.8%. Of the 143 cases with a UTI, 91 had a noninvasive UTI, 16 had a urosepsis confirmed by blood culture, 24 had a urosepsis based on clinical presentation, 11 had a pyelonephritis, and one had a prostatitis. Receiver operating characteristic curves of automated bacterial and leukocyte count showed area under the curve of 0.851 and 0.872, respectively. Cutoff values of 133 bacteria/μL and 48 leukocytes/μL resulted in a greater than 90% sensitivity.
The authors concluded that that in an unselected patient group presenting to the ED with suspected UTI, automated urine particle analysis with counts of leukocytes and bacteria results in comparable diagnostic accuracy compared with standard dipstick analysis but can slightly improve diagnostic accuracy, especially to make UTI unlikely, when added to standard clinical and UD analysis. The study was published in the August 2016 issue of the American Journal of Emergency Medicine.
Related Links:
University Medical Center Groningen
Roche Diagnostics
Sysmex Corporation
Latest Clinical Chem. News
- Carbon Nanotubes Help Build Highly Accurate Sensors for Continuous Health Monitoring
- Paper-Based Device Boosts HIV Test Accuracy from Dried Blood Samples
- AI-Powered Raman Spectroscopy Method Enables Rapid Drug Detection in Blood
- Novel LC-MS/MS Assay Detects Low Creatinine in Sweat and Saliva
- Biosensing Technology Breakthrough Paves Way for New Methods of Early Disease Detection
- New Saliva Test Rapidly Identifies Paracetamol Overdose
- POC Saliva Testing Device Predicts Heart Failure in 15 Minutes
- Screening Tool Detects Multiple Health Conditions from Single Blood Drop
- Integrated Chemistry and Immunoassay Analyzer with Extensive Assay Menu Offers Flexibility, Scalability and Data Commutability
- Rapid Drug Test to Improve Treatment for Patients Presenting to Hospital
- AI Model Detects Cancer at Lightning Speed through Sugar Analyses
- First-Ever Blood-Powered Chip Offers Real-Time Health Monitoring
- New ADLM Guidance Provides Expert Recommendations on Clinical Testing For Respiratory Viral Infections
- 3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models
- POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection
- Highly Reliable Cell-Based Assay Enables Accurate Diagnosis of Endocrine Diseases
Channels
Molecular Diagnostics
view channel
RNA-Based Blood Test Detects Preeclampsia Risk Months Before Symptoms
Preeclampsia remains a major cause of maternal morbidity and mortality, as well as preterm births. Despite current guidelines that aim to identify pregnant women at increased risk of preeclampsia using... Read more
First Of Its Kind Test Uses microRNAs to Predict Toxicity from Cancer Therapy
Many men with early-stage prostate cancer receive stereotactic body radiotherapy (SBRT), a highly precise form of radiation treatment that is completed in just five sessions. Compared to traditional radiation,... Read more
Novel Cell-Based Assay Provides Sensitive and Specific Autoantibody Detection in Demyelination
Anti-myelin-associated glycoprotein (MAG) antibodies serve as markers for an autoimmune demyelinating disorder that affects the peripheral nervous system, leading to sensory impairment. Anti-MAG-IgM antibodies... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
Handheld Device Deliver Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read morePathology
view channel
Advanced Imaging Reveals Mechanisms Causing Autoimmune Disease
Myasthenia gravis, an autoimmune disease, leads to muscle weakness that can affect a range of muscles, including those needed for basic actions like blinking, smiling, or moving. Researchers have long... Read more
AI Model Effectively Predicts Patient Outcomes in Common Lung Cancer Type
Lung adenocarcinoma, the most common form of non-small cell lung cancer (NSCLC), typically adopts one of six distinct growth patterns, often combining multiple patterns within a single tumor.... Read moreTechnology
view channel
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more